REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 122 filers reported holding REATA PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.69 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $371,000 | -31.4% | 6,613 | 0.0% | 0.04% | -27.1% |
| Q3 2018 | $541,000 | +67.5% | 6,613 | -28.5% | 0.06% | +59.5% |
| Q2 2018 | $323,000 | +70.0% | 9,244 | 0.0% | 0.04% | +60.9% |
| Q1 2018 | $190,000 | -27.5% | 9,244 | 0.0% | 0.02% | -28.1% |
| Q4 2017 | $262,000 | -8.7% | 9,244 | 0.0% | 0.03% | -17.9% |
| Q3 2017 | $287,000 | -1.7% | 9,244 | 0.0% | 0.04% | -9.3% |
| Q2 2017 | $292,000 | +39.7% | 9,244 | 0.0% | 0.04% | +30.3% |
| Q1 2017 | $209,000 | +3.5% | 9,244 | 0.0% | 0.03% | -2.9% |
| Q4 2016 | $202,000 | +61.6% | 9,244 | +94.8% | 0.03% | +54.5% |
| Q3 2016 | $125,000 | +33.0% | 4,746 | 0.0% | 0.02% | +22.2% |
| Q2 2016 | $94,000 | – | 4,746 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CPMG Inc | 2,896,901 | $288,821,000 | 55.24% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 100,000 | $9,970,000 | 15.20% |
| Tolleson Wealth Management, Inc. | 108,000 | $10,768,000 | 3.25% |
| MADDEN SECURITIES Corp | 34,787 | $3,468,000 | 2.03% |
| Biondo Investment Advisors, LLC | 101,204 | $10,090,000 | 2.01% |
| LBJ Family Wealth Advisors, Ltd. | 30,368 | $3,027,000 | 1.91% |
| Duquesne Family Office | 749,897 | $74,765,000 | 1.65% |
| Sofinnova Investments, Inc. | 238,520 | $23,780,000 | 1.43% |
| Camber Capital Management LP | 400,000 | $39,880,000 | 1.37% |
| Integral Health Asset Management, LLC | 44,000 | $4,387,000 | 1.25% |